Skip to main content

Kidneyhood.org’s Integrated Dietary Program Shows Clinically Significant Improvements in Patients with Stage 3, 4, and 5 Kidney Disease

By: Get News
Kidneyhood.org's Integrated Dietary Program Shows Clinically Significant Improvements in Patients with Stage 3, 4, and 5 Kidney Disease

Middleton, Wisconsin - December 5, 2024 - The results of a groundbreaking pilot study conducted by Kidneyhood.org proved its integrated dietary program led to clinically significant improvements in Stage 3, 4, and 5 kidney disease.

Kidneyhood.org, a patient-led initiative focused on improving healthcare options for individuals with incurable kidney disease, aims to develop clinically proven methods to extend the useful life of kidneys and delay the need for dialysis or transplant. The primary goal of the pilot study was to evaluate the effectiveness of a scientifically integrated dietary approach compared to traditional dietary strategies for managing kidney disease.

A New Era in Kidney Disease Management

As part of this new integrated approach, Kidneyhood.org developed new diets and related products: Albutrix S3, S4, and S5, a new keto acid analogs, and Microtrix, a low-serving vitamin supplement. These innovations, which have already resulted in four granted patents, were specifically created to meet the best practices for kidney disease management, ensuring that the specific nutritional needs of kidney disease patients are met.

 The results of the pilot study speak volumes:

  • 80% of patients saw eGFR improvement from baseline to six months, with an average increase of 25%.
  • 92% of patients showed a reduction in BUN levels, with over 80% achieving normal BUN levels, even though many started with levels far outside the normal range.
  • 86.2% experienced a reduction in creatinine levels, with an average 21% decrease in creatinine levels.
  • Blood glucose levels remained stable, ensuring the dietary approach was safe for diabetic patients.


These findings represent a significant breakthrough, demonstrating that an integrated approach, combined with patient education, has the potential to yield dramatically better results compared to previous dietary interventions, which often failed to show conclusive benefits. Larger studies are still needed to confirm early results.

A Vision for the Future

The dream for patients is to have access to a clinically proven form of kidney disease management that can help delay the progression of the disease, possibly for five to ten years, or even prevent the need for dialysis or a transplant altogether. Kidneyhood.org’s integrated dietary program aims to empower patients by providing the tools to take control of their health and extend the life of their kidneys.

With education and lifelong management at the core of the program, Kidneyhood.org offers a solution that is not only the least expensive and lowest risk but also significantly enhances patients’ quality of life. By teaching patients how to manage their condition effectively, this integrated approach presents a powerful, long-term solution that could revolutionize the way kidney disease is treated.

The success of this pilot study has laid the groundwork for a second pilot, which will build on the insights gained from the first study. If the second pilot is successful, Kidneyhood.org plans to collaborate with universities or hospitals to conduct a larger-scale study that could potentially influence kidney disease treatment worldwide.

Availability of Results

The full results of the pilot study are published in The Evidence-Based Guide to Kidney and Renal Diets, now available on Amazon.com and at www.kidneyhood.org. This book is the sixth installment in the Kidneyhood.org series, covering various aspects of kidney disease, from transplants and dialysis to diet management

About Kidneyhood.org

Kidneyhood.org is a patient-driven organization dedicated to improving the lives of those with kidney disease. Through research, education, and the development of innovative solutions, Kidneyhood.org seeks to extend kidney function, improve patient outcomes, and provide patients with the knowledge and tools to manage their condition effectively.

For more information, visit www.kidneyhood.org

Media Contact
Company Name: Kidneyhood.org
Contact Person: Lee Hull
Email: Send Email
Phone: 800-441-1045
City: Middleton
State: WI
Country: United States
Website: kidneyhood.org/

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.